Evidence map›Paper›PMID 41100451›Full record

ArticlePloS one2025

SARS-CoV-2 sequencing artifacts associated with targeted PCR enrichment and read mapping.

Kirsten Maren Ellegaard, Vithiagaran Gunalan, Raphael Sieber, Sharmin Jamshid Baig, Nicolai Balle Larsen, Marc Bennedbæk, Jonas Bybjerg-Grauholm, Leandro Andrés Escobar-Herrera, Tobias Gress, Theis Hass Thorsen and 7 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kirsten Maren EllegaardDepartment of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-1093-1645
Vithiagaran GunalanDepartment of Virology and Microbiological Preparedness, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-2020-9739
Raphael SieberDepartment of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-0372-128X
Sharmin Jamshid BaigDepartment of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-7929-2998
Nicolai Balle LarsenDepartment of Virology and Microbiological Preparedness, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-5105-7056
Marc BennedbækDepartment of Virology and Microbiological Preparedness, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-2753-5991
Jonas Bybjerg-GrauholmDepartment of Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-1705-4008
Leandro Andrés Escobar-HerreraDepartment of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-5671-5609
Tobias GressDepartment of Virology and Microbiological Preparedness, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0009-0005-5281-211X
Theis Hass ThorsenDepartment of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0009-0006-6920-8231
Anders KrusagerDepartment of Virology and Microbiological Preparedness, Statens Serum Institut, Copenhagen, Denmark.
Gitte Nygaard AasbjergDepartment of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0009-0004-5515-9964
Nour Saad Al-TamimiDepartment of Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
Casper WestergaardDepartment of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0009-0001-5040-2513
Christina Wiid SvarrerDepartment 318 CMC Bioanalysis, Novo Nordisk, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-5755-5520
Morten RasmussenDepartment of Virology and Microbiological Preparedness, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-7491-4137
Marc SteggerDepartment of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-0321-1180

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protocols and pipelines for SARS-CoV-2 genome sequencing were rapidly established when the COVID-19 outbreak was declared a pandemic. The most widely used approach for sequencing SARS-CoV-2 includes targeted enrichment by PCR, followed by shotgun sequencing and reference-based genome assembly. As the continued surveillance of SARS-CoV-2 worldwide is transitioning towards a lower level of intensity, it is timely to re-visit the sequencing protocols and pipelines established during the acute phase of the pandemic. In the current study, we have investigated the impact of primer scheme and reference genome choice by sequencing samples with multiple primer schemes (Artic V3, V4.1 and V5.3.2) and re-processing reads with multiple reference genomes. We have also analysed the temporal development in ambiguous base calls during the emergence of the BA.2.86.x variant. We found that the primers used for targeted enrichment can result in recurrent ambiguous base calls, which can accumulate rapidly in response to the emergence of a new variant. We also found examples of consistent base calling errors, associated with PCR artifacts and amplicon drop-out. Similarly, misalignments and partially mapped reads on the reference genome resulted in ambiguous base calls, as well as defining mutations being omitted from the assembly. These findings highlight some key limitations of using targeted enrichment by PCR and reference-based genome assembly for sequencing SARS-CoV-2, and the importance of continuously monitoring and updating primer schemes and bioinformatic pipelines.

Indexed as

COVID-19Polymerase Chain ReactionSARS-CoV-2ArtifactsGenome, ViralHigh-Throughput Nucleotide SequencingHumansWhole Genome Sequencing

Identifiers

PMID41100451
PMCPMC12530606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.